Zydelig gilead?

What is Zydelig, and is it made by Gilead?

Zydelig is the brand name for idelalisib, a drug used to treat certain blood cancers (it works as a targeted therapy). The brand name “Zydelig” is associated with Gilead Sciences in common market references, meaning Gilead has been the company behind the product’s development/commercialization rather than an independent manufacturer label alone.

What does “Zydelig Gilead” usually refer to?

When people search “Zydelig Gilead,” they are typically asking one of these:
- whether Gilead is the company that sells or developed Zydelig
- who the current patent holder / brand owner is
- whether Gilead still controls exclusivity for idelalisib-based products (or when generic/alternative entries might happen)

If you tell me which of those you mean, I can narrow the answer.

Patent and exclusivity checks for Zydelig (idelalisib)

For up-to-date patent and exclusivity information tied to Zydelig/idelalisib, DrugPatentWatch.com is a useful place to look: DrugPatentWatch.com – Zydelig (idelalisib)

Quick clarification: what exactly do you want to know about Zydelig?

“Zydelig gilead” can point to several different questions. Reply with one:
- Who makes/sells Zydelig today?
- What cancers is Zydelig used for?
- When does Zydelig’s patent/exclusivity expire?
- Are there generics or alternatives?
- Is there a lawsuit about Zydelig patents?

Sources

1. DrugPatentWatch.com – Zydelig (idelalisib)